| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
2 Department of Biochemistry, University of Iowa, Iowa City, IA, USA
* To whom correspondence should be addressed. E-mail: Lee.honchi{at}mayo.edu.
Arachidonic acid (AA) is a precursor of important vasoactive metabolites but the role of AA-mediated vasodilation in type 2 diabetes is not known. Using the Zucker Diabetic Fatty (ZDF) rats, we examined the effect of AA in small mesenteric arteries preconstricted with endothelin. In ZDF mesenteric arteries, 1 µM AA produced only one-third the amount of dilation as in vessels from Lean controls. In Lean controls, the AA effect was significantly and predominantly inhibited by the lipoxygenase inhibitors baicalein and cinnamyl-3,4-dihydroxycyanocinnamate (CDC). However, baicalein and CDC had no effect on AA-mediated dilation in ZDF mesenteric arteries. 12-Hydroxyeicosatetraenoic acid (12-HETE) was the major [3H]AA metabolite produced by isolated mesenteric arteries in both Lean and ZDF rats, but the amount of [3H]12-HETE produced by ZDF vessels was only 36% of that in controls. In addition, 12-HETE produced similar amounts of dilation in Lean and ZDF rat mesenteric arteries. Immunoblot analysis showed an 81% reduction in 12-lipoxygenase protein in ZDF mesenteric arteries. Immuofluorescence labeling showed strong nitrotyrosine signals in ZDF mesenteric arteries that co-localized with 12-lipoxygenase in the endothelium, and 12-lipoxygenase co-precipitation with anti-nitrotyrosine antibodies was enhanced in ZDF vessels. We conclude that AA-mediated relaxation in ZDF small mesenteric arteries is impaired due to reduced 12-lipoxygenase protein and activity. Increased oxidative stress and nitration of 12-lipoxygenase may underlie the impairment of AA-mediated relaxation in small mesenteric arteries of diabetic rats.
This article has been cited by other articles:
|
|
 |
|
  J. C. Frisbee, J. M. Hollander, R. W. Brock, H.-G. Yu, and M. A. Boegehold Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1771 - R1782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lu, T. He, Z. S. Katusic, and H.-C. Lee Molecular Mechanisms Mediating Inhibition of Human Large Conductance Ca2+-Activated K+ Channels by High Glucose Circ. Res., September 15, 2006; 99(6): 607 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ye, W. Zhou, T. Lu, S. G. Jagadeesh, J. R. Falck, and H.-C. Lee Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1326 - H1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lu, X.-L. Wang, T. He, W. Zhou, T. L. Kaduce, Z. S. Katusic, A. A. Spector, and H.-C. Lee Impaired Arachidonic Acid-Mediated Activation of Large-Conductance Ca2+-Activated K+ Channels in Coronary Arterial Smooth Muscle Cells in Zucker Diabetic Fatty Rats Diabetes, July 1, 2005; 54(7): 2155 - 2163. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
